The life sciences and healthcare (LSH) industry is at the frontline of battling the COVID-19 outbreak, unlike any other industry. Due to the novelty of the contagion and the lack of a vaccine yet, healthcare professionals (HCP) face the highest risk of getting infected since the mode of operations in medical facilities is largely contact-based. The situation demands that HCPs be equipped with advanced digital tools to stay safe while fulfilling their duty, both at present and in all such future circumstances.
While cloud, robotic process automation (RPA), and additive manufacturing (3D printing) are already being leveraged for drug formulation and equipment manufacturing, LSH institutions must also consider the scope of artificial intelligence (AI), machine learning (ML), internet of things (IoT), augmented reality (AR), virtual reality (VR), and other digital innovations in various medical functions and practices. Strategic use of these technologies is the key to resolving supply chain disruptions, drug shortage, and other crisis-induced challenges. It will also make clinical trials more efficient and add a new dimension to medical-related travels and marketing.
This blog post succinctly discusses how various technologies can resolve persistent challenges in the LSH industry and offer both immediate and long-term benefits.